Related references
Note: Only part of the references are listed.Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
Bo-Ying Bao et al.
CLINICAL CANCER RESEARCH (2011)
Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy
Shu-Pin Huang et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
A sex-specific role for androgens in angiogenesis
Daniel P. Sieveking et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways
Johan Svensson et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2010)
Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
Jian-Liang Chou et al.
LABORATORY INVESTIGATION (2010)
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
Llen L. Goode et al.
NATURE GENETICS (2010)
ARRDC3 suppresses breast cancer progression by negatively regulating integrin β4
K. M. Draheim et al.
ONCOGENE (2010)
Phase II study of sunitinib in men with advanced prostate cancer
M. Dror Michaelson et al.
ANNALS OF ONCOLOGY (2009)
Time to Prostate-Specific Antigen Nadir Independently Predicts Overall Survival in Patients Who Have Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen-Deprivation Therapy
Toni K. Choueiri et al.
CANCER (2009)
Prognostic Significance of Prostate Cancer Susceptibility Variants on Prostate-Specific Antigen Recurrence after Radical Prostatectomy
Shu-Pin Huang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
SKAP associates with kinetochores and promotes the metaphase-to-anaphase transition
Lin Fang et al.
CELL CYCLE (2009)
On the origins of arrestin and rhodopsin
Carlos E. Alvarez
BMC EVOLUTIONARY BIOLOGY (2008)
Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice
Helen E. MacLean et al.
FASEB JOURNAL (2008)
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer
Robert W. Ross et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
SKAP55 modulates T cell antigen receptor-induced activation of the Ras-Erk-AP1 pathway by binding RasGRP1
Karena A. Kosco et al.
MOLECULAR IMMUNOLOGY (2008)
Prognostic significance of p53 and X-ray repair cross-complementing group 1 Polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy
Shu-Pin Huang et al.
CLINICAL CANCER RESEARCH (2007)
Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC)
Charles J. Ryan et al.
INVESTIGATIONAL NEW DRUGS (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
PReMod: a database of genome-wide mammalian cis-regulatory module predictions
Vincent Ferretti et al.
NUCLEIC ACIDS RESEARCH (2007)
Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy
Shu-Pin Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)
Maha Hussain et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The International HapMap Project Web site
GA Thorisson et al.
GENOME RESEARCH (2005)
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure
AJ Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population
SP Huang et al.
CANCER LETTERS (2004)
Androgen receptor in prostate cancer
CA Heinlein et al.
ENDOCRINE REVIEWS (2004)
The UCSC Table Browser data retrieval tool
D Karolchik et al.
NUCLEIC ACIDS RESEARCH (2004)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Program-specific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling
J Zeitlinger et al.
CELL (2003)
Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer
C Kwak et al.
JOURNAL OF UROLOGY (2002)
Share Paper
